Advertisement

Index by author

May 01, 1991; Volume 39,Issue 5

A

  1. Audinat, E

    1. Reduction of desensitization of a glutamate ionotropic receptor by antagonists.
      M Geoffroy, B Lambolez, E Audinat, B Hamon, F Crepel, J Rossier and R T Kado
      Molecular Pharmacology May 1991, 39 (5) 587-591;

B

  1. Barchi, R L

    1. SkM2, a Na+ channel cDNA clone from denervated skeletal muscle, encodes a tetrodotoxin-insensitive Na+ channel.
      M M White, L Q Chen, R Kleinfield, R G Kallen and R L Barchi
      Molecular Pharmacology May 1991, 39 (5) 604-608;

  2. Barton, A C

    1. Agonist-induced desensitization of D2 dopamine receptors in human Y-79 retinoblastoma cells.
      A C Barton, L E Black and D R Sibley
      Molecular Pharmacology May 1991, 39 (5) 650-658;

  3. Beddell, C R

    1. Application of pattern recognition methods to the analysis and classification of toxicological data derived from proton nuclear magnetic resonance spectroscopy of urine.
      K P Gartland, C R Beddell, J C Lindon and J K Nicholson
      Molecular Pharmacology May 1991, 39 (5) 629-642;

  4. Bernad, N

    1. Pharmacological characterization of type B cholecystokinin binding sites on the human JURKAT T lymphocyte cell line.
      M F Lignon, N Bernad and J Martinez
      Molecular Pharmacology May 1991, 39 (5) 615-620;

  5. Black, L E

    1. Agonist-induced desensitization of D2 dopamine receptors in human Y-79 retinoblastoma cells.
      A C Barton, L E Black and D R Sibley
      Molecular Pharmacology May 1991, 39 (5) 650-658;

  6. Bovolin, P

    1. Regulation of gamma-aminobutyric acidA receptor subunit expression by activation of N-methyl-D-aspartate-selective glutamate receptors.
      M Memo, P Bovolin, E Costa and D R Grayson
      Molecular Pharmacology May 1991, 39 (5) 599-603;

  7. Brüne, B

    1. 12-hydroperoxyeicosatetraenoic acid inhibits main platelet functions by activation of soluble guanylate cyclase.
      B Brüne and V Ullrich
      Molecular Pharmacology May 1991, 39 (5) 671-678;

C

  1. Chen, C H

    1. Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity.
      C H Chen, M Vazquez-Padua and Y C Cheng
      Molecular Pharmacology May 1991, 39 (5) 625-628;

  2. Chen, L Q

    1. SkM2, a Na+ channel cDNA clone from denervated skeletal muscle, encodes a tetrodotoxin-insensitive Na+ channel.
      M M White, L Q Chen, R Kleinfield, R G Kallen and R L Barchi
      Molecular Pharmacology May 1991, 39 (5) 604-608;

  3. Cheng, Y C

    1. Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity.
      C H Chen, M Vazquez-Padua and Y C Cheng
      Molecular Pharmacology May 1991, 39 (5) 625-628;

  4. Costa, E

    1. Regulation of gamma-aminobutyric acidA receptor subunit expression by activation of N-methyl-D-aspartate-selective glutamate receptors.
      M Memo, P Bovolin, E Costa and D R Grayson
      Molecular Pharmacology May 1991, 39 (5) 599-603;

  5. Crepel, F

    1. Reduction of desensitization of a glutamate ionotropic receptor by antagonists.
      M Geoffroy, B Lambolez, E Audinat, B Hamon, F Crepel, J Rossier and R T Kado
      Molecular Pharmacology May 1991, 39 (5) 587-591;

D

  1. Di Paolo, T

    1. Dopamine receptor reappearance after irreversible receptor blockade: effect of chronic estradiol treatment of ovariectomized rats.
      D Lévesque and T Di Paolo
      Molecular Pharmacology May 1991, 39 (5) 659-665;

F

  1. Flagg, S

    1. Production of antisera selective for m1 muscarinic receptors using fusion proteins: distribution of m1 receptors in rat brain.
      S J Wall, R P Yasuda, F Hory, S Flagg, B M Martin, E I Ginns and B B Wolfe
      Molecular Pharmacology May 1991, 39 (5) 643-649;

G

  1. Gartland, K P

    1. Application of pattern recognition methods to the analysis and classification of toxicological data derived from proton nuclear magnetic resonance spectroscopy of urine.
      K P Gartland, C R Beddell, J C Lindon and J K Nicholson
      Molecular Pharmacology May 1991, 39 (5) 629-642;

  2. Geoffroy, M

    1. Reduction of desensitization of a glutamate ionotropic receptor by antagonists.
      M Geoffroy, B Lambolez, E Audinat, B Hamon, F Crepel, J Rossier and R T Kado
      Molecular Pharmacology May 1991, 39 (5) 587-591;

  3. Ginns, E I

    1. Production of antisera selective for m1 muscarinic receptors using fusion proteins: distribution of m1 receptors in rat brain.
      S J Wall, R P Yasuda, F Hory, S Flagg, B M Martin, E I Ginns and B B Wolfe
      Molecular Pharmacology May 1991, 39 (5) 643-649;

  4. Grayson, D R

    1. Regulation of gamma-aminobutyric acidA receptor subunit expression by activation of N-methyl-D-aspartate-selective glutamate receptors.
      M Memo, P Bovolin, E Costa and D R Grayson
      Molecular Pharmacology May 1991, 39 (5) 599-603;

  5. Guthrie, T S

    1. A synthetic pseudosubstrate peptide of protein kinase C inhibits the phorbol-12,13-dibutyrate effect on permeabilized coronary artery smooth muscle.
      T S Guthrie, J Tsuji and J N Wells
      Molecular Pharmacology May 1991, 39 (5) 621-624;

H

  1. Hamon, B

    1. Reduction of desensitization of a glutamate ionotropic receptor by antagonists.
      M Geoffroy, B Lambolez, E Audinat, B Hamon, F Crepel, J Rossier and R T Kado
      Molecular Pharmacology May 1991, 39 (5) 587-591;

  2. Hershkowitz, N

    1. Tetrahydroaminoacridine block of N-methyl-D-aspartate-activated cation channels in cultured hippocampal neurons.
      N Hershkowitz and M A Rogawski
      Molecular Pharmacology May 1991, 39 (5) 592-598;

  3. Hill, R J

    1. Aminoalkyl structural requirements for interaction of lidocaine with the class I antiarrhythmic drug receptor on rat cardiac myocytes.
      R S Sheldon, R J Hill, M Taouis and L M Wilson
      Molecular Pharmacology May 1991, 39 (5) 609-614;

  4. Hory, F

    1. Production of antisera selective for m1 muscarinic receptors using fusion proteins: distribution of m1 receptors in rat brain.
      S J Wall, R P Yasuda, F Hory, S Flagg, B M Martin, E I Ginns and B B Wolfe
      Molecular Pharmacology May 1991, 39 (5) 643-649;

K

  1. Kado, R T

    1. Reduction of desensitization of a glutamate ionotropic receptor by antagonists.
      M Geoffroy, B Lambolez, E Audinat, B Hamon, F Crepel, J Rossier and R T Kado
      Molecular Pharmacology May 1991, 39 (5) 587-591;

  2. Kallen, R G

    1. SkM2, a Na+ channel cDNA clone from denervated skeletal muscle, encodes a tetrodotoxin-insensitive Na+ channel.
      M M White, L Q Chen, R Kleinfield, R G Kallen and R L Barchi
      Molecular Pharmacology May 1991, 39 (5) 604-608;

  3. Kemp, J A

    1. Effects of (+)-HA-966 and 7-chlorokynurenic acid on the kinetics of N-methyl-D-aspartate receptor agonist responses in rat cultured cortical neurons.
      J A Kemp and T Priestley
      Molecular Pharmacology May 1991, 39 (5) 666-670;

  4. Kleinfield, R

    1. SkM2, a Na+ channel cDNA clone from denervated skeletal muscle, encodes a tetrodotoxin-insensitive Na+ channel.
      M M White, L Q Chen, R Kleinfield, R G Kallen and R L Barchi
      Molecular Pharmacology May 1991, 39 (5) 604-608;

L

  1. Lambolez, B

    1. Reduction of desensitization of a glutamate ionotropic receptor by antagonists.
      M Geoffroy, B Lambolez, E Audinat, B Hamon, F Crepel, J Rossier and R T Kado
      Molecular Pharmacology May 1991, 39 (5) 587-591;

  2. Lévesque, D

    1. Dopamine receptor reappearance after irreversible receptor blockade: effect of chronic estradiol treatment of ovariectomized rats.
      D Lévesque and T Di Paolo
      Molecular Pharmacology May 1991, 39 (5) 659-665;

  3. Lignon, M F

    1. Pharmacological characterization of type B cholecystokinin binding sites on the human JURKAT T lymphocyte cell line.
      M F Lignon, N Bernad and J Martinez
      Molecular Pharmacology May 1991, 39 (5) 615-620;

  4. Lindon, J C

    1. Application of pattern recognition methods to the analysis and classification of toxicological data derived from proton nuclear magnetic resonance spectroscopy of urine.
      K P Gartland, C R Beddell, J C Lindon and J K Nicholson
      Molecular Pharmacology May 1991, 39 (5) 629-642;

M

  1. Martin, B M

    1. Production of antisera selective for m1 muscarinic receptors using fusion proteins: distribution of m1 receptors in rat brain.
      S J Wall, R P Yasuda, F Hory, S Flagg, B M Martin, E I Ginns and B B Wolfe
      Molecular Pharmacology May 1991, 39 (5) 643-649;

  2. Martinez, J

    1. Pharmacological characterization of type B cholecystokinin binding sites on the human JURKAT T lymphocyte cell line.
      M F Lignon, N Bernad and J Martinez
      Molecular Pharmacology May 1991, 39 (5) 615-620;

  3. Memo, M

    1. Regulation of gamma-aminobutyric acidA receptor subunit expression by activation of N-methyl-D-aspartate-selective glutamate receptors.
      M Memo, P Bovolin, E Costa and D R Grayson
      Molecular Pharmacology May 1991, 39 (5) 599-603;

N

  1. Nicholson, J K

    1. Application of pattern recognition methods to the analysis and classification of toxicological data derived from proton nuclear magnetic resonance spectroscopy of urine.
      K P Gartland, C R Beddell, J C Lindon and J K Nicholson
      Molecular Pharmacology May 1991, 39 (5) 629-642;

P

  1. Pessah, I N

    1. Characterization of multiple [3H]ryanodine binding sites on the Ca2+ release channel of sarcoplasmic reticulum from skeletal and cardiac muscle: evidence for a sequential mechanism in ryanodine action.
      I N Pessah and I Zimanyi
      Molecular Pharmacology May 1991, 39 (5) 679-689;

  2. Priestley, T

    1. Effects of (+)-HA-966 and 7-chlorokynurenic acid on the kinetics of N-methyl-D-aspartate receptor agonist responses in rat cultured cortical neurons.
      J A Kemp and T Priestley
      Molecular Pharmacology May 1991, 39 (5) 666-670;

R

  1. Rogawski, M A

    1. Tetrahydroaminoacridine block of N-methyl-D-aspartate-activated cation channels in cultured hippocampal neurons.
      N Hershkowitz and M A Rogawski
      Molecular Pharmacology May 1991, 39 (5) 592-598;

  2. Rossier, J

    1. Reduction of desensitization of a glutamate ionotropic receptor by antagonists.
      M Geoffroy, B Lambolez, E Audinat, B Hamon, F Crepel, J Rossier and R T Kado
      Molecular Pharmacology May 1991, 39 (5) 587-591;

S

  1. Sheldon, R S

    1. Aminoalkyl structural requirements for interaction of lidocaine with the class I antiarrhythmic drug receptor on rat cardiac myocytes.
      R S Sheldon, R J Hill, M Taouis and L M Wilson
      Molecular Pharmacology May 1991, 39 (5) 609-614;

  2. Sibley, D R

    1. Agonist-induced desensitization of D2 dopamine receptors in human Y-79 retinoblastoma cells.
      A C Barton, L E Black and D R Sibley
      Molecular Pharmacology May 1991, 39 (5) 650-658;

T

  1. Taouis, M

    1. Aminoalkyl structural requirements for interaction of lidocaine with the class I antiarrhythmic drug receptor on rat cardiac myocytes.
      R S Sheldon, R J Hill, M Taouis and L M Wilson
      Molecular Pharmacology May 1991, 39 (5) 609-614;

  2. Tsuji, J

    1. A synthetic pseudosubstrate peptide of protein kinase C inhibits the phorbol-12,13-dibutyrate effect on permeabilized coronary artery smooth muscle.
      T S Guthrie, J Tsuji and J N Wells
      Molecular Pharmacology May 1991, 39 (5) 621-624;

U

  1. Ullrich, V

    1. 12-hydroperoxyeicosatetraenoic acid inhibits main platelet functions by activation of soluble guanylate cyclase.
      B Brüne and V Ullrich
      Molecular Pharmacology May 1991, 39 (5) 671-678;

V

  1. Vazquez-Padua, M

    1. Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity.
      C H Chen, M Vazquez-Padua and Y C Cheng
      Molecular Pharmacology May 1991, 39 (5) 625-628;

W

  1. Wall, S J

    1. Production of antisera selective for m1 muscarinic receptors using fusion proteins: distribution of m1 receptors in rat brain.
      S J Wall, R P Yasuda, F Hory, S Flagg, B M Martin, E I Ginns and B B Wolfe
      Molecular Pharmacology May 1991, 39 (5) 643-649;

  2. Wells, J N

    1. A synthetic pseudosubstrate peptide of protein kinase C inhibits the phorbol-12,13-dibutyrate effect on permeabilized coronary artery smooth muscle.
      T S Guthrie, J Tsuji and J N Wells
      Molecular Pharmacology May 1991, 39 (5) 621-624;

  3. White, M M

    1. SkM2, a Na+ channel cDNA clone from denervated skeletal muscle, encodes a tetrodotoxin-insensitive Na+ channel.
      M M White, L Q Chen, R Kleinfield, R G Kallen and R L Barchi
      Molecular Pharmacology May 1991, 39 (5) 604-608;

  4. Wilson, L M

    1. Aminoalkyl structural requirements for interaction of lidocaine with the class I antiarrhythmic drug receptor on rat cardiac myocytes.
      R S Sheldon, R J Hill, M Taouis and L M Wilson
      Molecular Pharmacology May 1991, 39 (5) 609-614;

  5. Wolfe, B B

    1. Production of antisera selective for m1 muscarinic receptors using fusion proteins: distribution of m1 receptors in rat brain.
      S J Wall, R P Yasuda, F Hory, S Flagg, B M Martin, E I Ginns and B B Wolfe
      Molecular Pharmacology May 1991, 39 (5) 643-649;

Y

  1. Yasuda, R P

    1. Production of antisera selective for m1 muscarinic receptors using fusion proteins: distribution of m1 receptors in rat brain.
      S J Wall, R P Yasuda, F Hory, S Flagg, B M Martin, E I Ginns and B B Wolfe
      Molecular Pharmacology May 1991, 39 (5) 643-649;

Z

  1. Zimanyi, I

    1. Characterization of multiple [3H]ryanodine binding sites on the Ca2+ release channel of sarcoplasmic reticulum from skeletal and cardiac muscle: evidence for a sequential mechanism in ryanodine action.
      I N Pessah and I Zimanyi
      Molecular Pharmacology May 1991, 39 (5) 679-689;
Back to top

In this issue

Advertisement